MYOSIN THERAPEUTICS
Myosin Therapeutics is a privately-held biopharmaceutical company developing novel medications for CNS-based disorders
MYOSIN THERAPEUTICS
Industry:
Biotechnology
Address:
Jupiter, Florida, United States
Country:
United States
Website Url:
http://www.myosintherapeutics.com
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Content Delivery Network Euro Typekit Shutterstock Squarespace Squarespace Add To Cart
Current Employees Featured
Official Site Inspections
http://www.myosintherapeutics.com
- Host name: mdns3.hostwindsdns.com
- IP address: 104.168.156.55
- Location: Seattle United States
- Latitude: 47.4902
- Longitude: -122.3004
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98168
More informations about "Myosin Therapeutics"
Myosin Therapeutics
We are focused on developing therapies for central nervous system and oncology indications with a platform designed for targeting molecular nanomotor proteins. Our lead programs for โฆSee details»
Myosin Therapeutics Inc. | LinkedIn
Developing next generation therapeutics targeting molecular motors | The mission of Myosin Therapeutics, Inc. is to improve health outcomes through the development of novel pharmacotherapies...See details»
Myosin Therapeutics Closes Seed Round to Continue โฆ
Mar 14, 2023ย ยท Myosin Therapeutics, Inc. (the "Company") is developing its lead compound, MT-125, to treat glioblastoma, which is a highly aggressive form of brain cancer with a 95% fatality rate and limited...See details»
Contact - Myosin Therapeutics
One of our representatives will contact you soon. ฮSee details»
Myosin Therapeutics - Crunchbase Company Profile & Funding
Myosin Therapeutics is a privately-held biopharmaceutical company developing novel medications for CNS-based disorders. The company specializes in molecular machines that turn energy โฆSee details»
Myosin Therapeutics Company Profile 2024: Valuation, โฆ
Operator of a biopharmaceutical company intended to treat significant unmet medical needs. The company focuses on developing novel medications targeting cellular motor proteins and specializes in molecular machines that convert โฆSee details»
Myosin Therapeutics Closes Seed Round to Continue ... - BioSpace
Mar 14, 2023ย ยท Myosin Therapeutics Inc. announced that it supplemented its National Institutes of Health funding with a seed funding round to advance the companyโs lead programs on โฆSee details»
Myosin Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Myosin Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 4 news, Disease Domain:Nervous System Diseases, Neoplasms, Technology ...See details»
Myosin Therapeutics, Inc. | DeepWork Capital | Florida
Myosin Therapeutics, Inc. - Biopharmaceutical company in Jupiter, FL developing medications targeting cellular motor proteins. Explore 'nMotor Platform' technology and candidates for โฆSee details»
MYOSIN THERAPEUTICS INC | SBIR.gov
PROJECT SUMMARYAn area of significant unmet need is the treatment of glioblastoma (GBM), an aggressive, fast-growing and lethal brain cancer that represents 48% of all malignant brain โฆSee details»
Small Business - Harlan Enterprise | Harlan Enterprise
To learn more about the company, please visit www.myosintherapeutics.com. Mint12 Pharma invests in new patented core pharmaceutical and biotech technologies that have the potential โฆSee details»
MYOSIN THERAPEUTICS INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for MYOSIN THERAPEUTICS INC. of Jupiter, FL. Get the latest business insights from Dun & Bradstreet.See details»
Founder Lodge | Myosin Therapeutics Inc. raises at Seed on 2023 โฆ
Mar 16, 2023ย ยท The mission of Myosin Therapeutics, Inc. is to improve health outcomes through the development of novel pharmacotherapies targeting members of the myosin family of โฆSee details»
Myosin Therapeutics Closes Seed Round to Continue โฆ
JUPITER, Fla., March 14, 2023 /PRNewswire/ -- Myosin Therapeutics Inc., a biotechnology company leveraging its innovative platform technology to identify new molecular entities โฆSee details»
Myosin Therapeutics - VentureRadar
Develops novel compound, MT-125, targeting aggressive brain cancer, glioblastoma, with a high fatality rate and limited treatment options; demonstrates simultaneous effects in early models.See details»
Myosin Therapeutics - Products, Competitors, Financials, โฆ
Myosin Therapeutics is a biopharmaceutical company focused on developing novel medications targeting cellular motor proteins within the healthcare sector.See details»
Myosin Therapeutics - Overview, News & Similar companies
Myosin Therapeutics Inc is a company that operates in the Biotechnology industry. It employs 6-10 people and has $1M-$5M of revenue. The company is Read more. Is this data correct? โฆSee details»
Myosin Therapeutics Closes Seed Round to Continue โฆ
Mar 14, 2023ย ยท Myosin Therapeutics, Inc. (the "Company") is developing its lead compound, MT-125, to treat glioblastoma, which is a highly aggressive form of brain cancer with a 95% fatality โฆSee details»
Myosin Therapeutics - Company Profile - Tracxn
Oct 31, 2024ย ยท Developer of therapeutics for CNS-based disorders. The company has small molecule modulators which include MT-125 for different cancers, MT-110 for METH use โฆSee details»
Myosin Therapeutics - VentureRadar
Similar Companies: Apogenix Germany Privately Held Apogenix, a 2005 spin-out from the German Cancer Research Center (DKFZ), is developing novel protein therapeutics for the โฆSee details»